Nutrition Education Program in Spinal Cord Injury (SCI)

Sponsor
University of Miami (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05953597
Collaborator
The Craig H. Neilsen Foundation (Other)
20
1
1
15
1.3

Study Details

Study Description

Brief Summary

The purpose of this research is to assess the effectiveness of a nutrition education program in increasing nutrition knowledge and improving health-related biomarkers in individuals with spinal cord injury (SCI).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Nutrition Education
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Effectiveness of a Nutrition Education Program in Improving Nutrition Knowledge and Related Biomarkers in Individuals With Spinal Cord Injury
Anticipated Study Start Date :
Oct 1, 2023
Anticipated Primary Completion Date :
Jan 1, 2025
Anticipated Study Completion Date :
Jan 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Nutrition Education Group

Participants in this study arm will receive nutrition education once a month for 12 months.

Behavioral: Nutrition Education
The intervention will consist of 12 monthly nutrition education sessions catered to people with spinal cord injuries. The curriculum is based on the 2020-2025 Dietary Guidelines for Americans such as consuming recommended amounts of fruits/vegetables, whole grains, etc. The sessions will be approximately 30-60 minutes and will be available in-person.

Outcome Measures

Primary Outcome Measures

  1. Change in Nutrition Knowledge [Baseline, 12 months]

    The General Nutrition Knowledge Questionnaire is an 88-item scale that has a scoring range of 0 to 88 with a high score indicating more knowledge of nutrition.

Secondary Outcome Measures

  1. Change in Cardiometabolic Biomarkers - Fasting Sodium [Baseline, 12 months]

    Measured in millimoles/liter assessed with blood analyses.

  2. Change in Cardiometabolic Biomarkers - Potassium [Baseline, 12 months]

    Measured in millimoles/liter assessed with blood analyses.

  3. Change in Cardiometabolic Biomarkers - Chloride [Baseline, 12 months]

    Measured in millimoles/liter assessed with blood analyses.

  4. Change in Cardiometabolic Biomarkers - Blood Urea Nitrogen [Baseline, 12 months]

    Measured in milligrams/deciliter assessed with blood analyses.

  5. Change in Cardiometabolic Biomarkers - Glucose [Baseline, 12 months]

    Measured in milligrams/deciliter assessed with blood analyses.

  6. Change in Cardiometabolic Biomarkers -Triglycerides [Baseline, 12 months]

    Measured in milligrams/deciliter assessed with blood analyses.

  7. Change in Cardiometabolic Biomarkers - Total Cholesterol [Baseline, 12 months]

    Measured in milligrams/deciliter assessed with blood analyses.

  8. Change in Cardiometabolic Biomarkers - Low Density Lipoprotein Cholesterol [Baseline, 12 months]

    Measured in milligrams/deciliter assessed with blood analyses.

  9. Change in Cardiometabolic Biomarkers - Very-low-density lipoprotein [Baseline, 12 months]

    Measured in milligrams/deciliter assessed with blood analyses.

  10. Change in Cardiometabolic Biomarkers -High-density lipoprotein cholesterol [Baseline, 12 months]

    Measured in milligrams/deciliter assessed with blood analyses.

  11. Change in Cardiometabolic Biomarkers - Hemoglobin a1c [Baseline, 12 months]

    Measured as a percentage of hemoglobin a1c, assessed with blood analyses.

  12. Change in Cardiometabolic Biomarkers - Insulin [Baseline, 12 months]

    Measured in units of insulin per millimeter (uU/ml) assessed with blood analyses.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adults with SCI with complete and incomplete (American Spinal Injury Association Impairment Scale Score A-D) paraplegia or ventilator-independent tetraplegia.
Exclusion Criteria:
  • Participants who do not meet inclusion criteria.

  • Adults unable to consent.

  • Individuals who are not yet adults (infants, children, teenagers)

  • Pregnant women (self-report)

  • Prisoners

Contacts and Locations

Locations

Site City State Country Postal Code
1 Christine E. Lynn Rehabilitation Center Miami Florida United States 33136

Sponsors and Collaborators

  • University of Miami
  • The Craig H. Neilsen Foundation

Investigators

  • Principal Investigator: Elizabeth R Felix, PhD, University of Miami

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Elizabeth Felix, Research Professor, University of Miami
ClinicalTrials.gov Identifier:
NCT05953597
Other Study ID Numbers:
  • 20230569
First Posted:
Jul 20, 2023
Last Update Posted:
Jul 20, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Elizabeth Felix, Research Professor, University of Miami
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 20, 2023